BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ulrich medical USA, Inc. Announces Two Product Line Enhancements


4/2/2012 12:08:28 PM

ST. LOUIS, April 2, 2012 /PRNewswire/-- ulrich medicalUSA, Inc. today announced the release of two important product line enhancements to their growing spinal implant portfolio of expandable cage technologies.

The first product enhancement is the introduction of a 4.0 mm osmium screw for the ADDplusimplant which is used for vertebral body replacement in the thoracolumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body due to trauma or tumor. As its name suggests, the ADDplus is an expandable anterior distraction device which is innovatively designed with pre-attached, low-profile fixation plates and it is the only implant of its kind currently available on the US market.

The second enhancement to the VBR® product lines was made to the obelisc® implant system with the release of a new short locking center screw which allows for maximum bone or bone substitute materials to be placed inside the cage for enhanced fusion.

"Over the past 18 months, we have spent a great deal of time understanding the requirements of the US spine market and we have received valuable surgeon feedback related to our implant systems and instrumentation. As a result, we are introducing new features to our cage technologies that will allow for broader US market acceptance moving forward," said Erika Laskey, Vice President of Sales and Marketing, ulrich medicalUSA.

For more information, please visit www.ulrichmedicalusa.com.

About ulrich medicalUSA, Inc.

ulrich medicalUSA, Inc. is a privately-held subsidiary of ulrich medical® Inc., an innovative medical technology company headquartered in Ulm, Germany which is celebrating its 100th year in business in 2012.

Company Contact:
info@ulrichmedicalusa.com

SOURCE ulrich medical USA, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES